{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:31:10Z","timestamp":1725665470287},"publisher-location":"Basel","reference-count":15,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034872942"},{"type":"electronic","value":"9783034872928"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/978-3-0348-7292-8_8","type":"book-chapter","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T09:40:53Z","timestamp":1330335653000},"page":"83-96","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological Screening for Potentially Carcinogenic Drugs"],"prefix":"10.1007","author":[{"given":"G. D.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. V.","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0025-6196(12)64947-7","volume":"63","author":"CN Beard","year":"1988","unstructured":"Beard, C.N., Noller, K.L., O\u2019Fallon, W.M., et al. (1988) Mayo Clin. Proc. 63, 147\u2013153.","journal-title":"Mayo Clin. Proc."},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0021-9681(72)90017-3","volume":"25","author":"GD Friedman","year":"1972","unstructured":"Friedman, G.D. (1972) J. Chronic Dis. 25, 11\u201320.","journal-title":"J. Chronic Dis."},{"key":"8_CR3","first-page":"291","volume":"67","author":"GD Friedman","year":"1981","unstructured":"Friedman, G.D. (1981) J. Natl. Cancer Inst. 67, 291\u2013295.","journal-title":"J. Natl. Cancer Inst."},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0021-9681(82)90079-0","volume":"35","author":"GD Friedman","year":"1982","unstructured":"Friedman, G.D. (1982) J. Chronic Dis. 35, 233\u2013243.","journal-title":"J. Chronic Dis."},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ije\/12.3.375","volume":"12","author":"GD Friedman","year":"1983","unstructured":"Friedman, G.D. (1983) Int. J. Epidemiol. 12, 375\u2013376.","journal-title":"Int. J. Epidemiol."},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0021-9681(83)90168-6","volume":"36","author":"GD Friedman","year":"1983","unstructured":"Friedman, G.D. (1983a) J. Chronic Dis. 36, 367\u2013370.","journal-title":"J. Chronic Dis."},{"key":"8_CR7","unstructured":"Friedman, G.D. (In press) In: Pharmacoepidemiology: The Science of Postmarketing Drug Surveillance (B.L. Strom, Ed), Churchill Livingstone, New York."},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.1989.03420060070035","volume":"261","author":"GD Friedman","year":"1989","unstructured":"Friedman, G.D., and Selby, J.V. (1989) J. Am. Med. Assoc. 261, 866.","journal-title":"J. Am. Med. Assoc."},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/65.4.723","volume":"65","author":"GD Friedman","year":"1980","unstructured":"Friedman, G.D., and Ury, H.K. (1980) J. Natl. Cancer Inst. 65, 723\u2013733.","journal-title":"J. Natl. Cancer Inst."},{"key":"8_CR10","first-page":"1165","volume":"71","author":"GD Friedman","year":"1983","unstructured":"Friedman, G.D., and Ury, H.K. (1983) J. Natl. Cancer Inst. 71, 1165\u20131175.","journal-title":"J. Natl. Cancer Inst."},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jama.1971.03190050025005","volume":"217","author":"GD Friedman","year":"1971","unstructured":"Friedman, G.D., Collen, M.F., Harris, L.E., Van Brunt, E.E., and Davis, L.S. (1971) J. Am. Med. Assoc. 217, 567\u2013572.","journal-title":"J. Am. Med. Assoc."},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ki.1982.133","volume":"22","author":"RA Hiatt","year":"1982","unstructured":"Hiatt, R.A., and Friedman, G.D. (1982) Kidney Int. 22, 63\u201368.","journal-title":"Kidney Int."},{"key":"8_CR13","volume-title":"IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans (Suppl 7), vol. 1\u201342","author":"International Agency for Research on Cancer","year":"1987","unstructured":"International Agency for Research on Cancer. (1987) In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans (Suppl 7), vol. 1\u201342. IARC, Lyon, France."},{"key":"8_CR14","unstructured":"Selby, J.V., and Friedman, G.D. (Submitted) Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up."},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jnci\/61.1.113","volume":"61","author":"RR Williams","year":"1978","unstructured":"Williams, R.R., Feinleib, M., Connor, R.J., and Stegens, N.L. (1978) J. Natl. Cancer Inst. 61, 327\u2013335.","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Risk Factors for Adverse Drug Reactions \u2014 Epidemiological Approaches"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-7292-8_8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T16:31:30Z","timestamp":1619973090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-7292-8_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"ISBN":["9783034872942","9783034872928"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-7292-8_8","relation":{},"subject":[],"published":{"date-parts":[[1990]]}}}